Asset Dedication LLC’s Emergent Biosolutions EBS Stock Holding History

Asset Dedication LLC’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2	Closed	–	–	661
2018 Q2	$0	Buy	+2	New	+$104	﹤0.01%	648

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Asset Dedication LLC's EBS Position: Q3 2018 in Review

Asset Dedication LLC sold out of Emergent Biosolutions (EBS) in Q3 2018, closing a stake of 2 shares.

Asset Dedication LLC first reported a position in EBS in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 275 funds tracked by Wall St. Rank hold EBS as of Q3 2018.

Asset Dedication LLC reported no remaining Emergent Biosolutions position as of Q3 2018 after selling out during the quarter.
Asset Dedication LLC sold 2 Emergent Biosolutions shares in Q3 2018.
Asset Dedication LLC first reported a position in Emergent Biosolutions in Q2 2018 and held it in 1 quarter.
Asset Dedication LLC's Emergent Biosolutions position peaked at $0 in Q2 2018.
275 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2018.

Based on Asset Dedication LLC's 13F filing for Q3 2018, filed 26 Oct 2018.